![](/img/cover-not-exists.png)
A randomized, double-blind study of the efficacy and safety of oral ganciclovir for the prevention of cytomegalovirus disease in HIV-infected persons: J. P. Lalezari for the SYNTEX GANCICLOVIR STUDY GROUP, Mount Zion Medical Center, UCSF, S.F., CA and Syntex Research, Palo Alto, CA
Volume:
26
Year:
1995
Language:
english
Pages:
1
DOI:
10.1016/0166-3542(95)94921-n
File:
PDF, 61 KB
english, 1995